Adiponectin as Link Factor between Adipose Tissue and Cancer
- PMID: 30781341
- PMCID: PMC6412253
- DOI: 10.3390/ijms20040839
Adiponectin as Link Factor between Adipose Tissue and Cancer
Abstract
Adipose tissue is a key regulator of energy balance playing an active role in lipid storage as well as in synthesizing several hormones directly involved in the pathogenesis of obesity. Obesity represents a peculiar risk factor for a growing list of cancers and is frequently associated to poor clinical outcome. The mechanism linking obesity and cancer is not completely understood, but, amongst the major players, there are both chronic low-grade inflammation and deregulation of adipokines secretion. In obesity, the adipose tissue is pervaded by an abnormal number of immune cells that create an inflammatory environment supporting tumor cell proliferation and invasion. Adiponectin (APN), the most abundant adipokine, shows anti-inflammatory, anti-proliferative and pro-apoptotic properties. Circulating levels of APN are drastically decreased in obesity, suggesting that APN may represent the link factor between obesity and cancer risk. The present review describes the recent advances on the involvement of APN and its receptors in the etiology of different types of cancer.
Keywords: Adiponectin; Adiponectin receptors; cancer; inflammation; inflammatory response; nutritional status; obesity.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk.Int J Mol Sci. 2019 Jun 12;20(12):2863. doi: 10.3390/ijms20122863. Int J Mol Sci. 2019. PMID: 31212761 Free PMC article. Review.
-
Adiponectin: anti-inflammatory and cardioprotective effects.Biochimie. 2012 Oct;94(10):2143-9. doi: 10.1016/j.biochi.2012.06.030. Epub 2012 Jul 13. Biochimie. 2012. PMID: 22796520 Review.
-
Adipokines identified as new downstream targets for adiponectin: lessons from adiponectin-overexpressing or -deficient mice.Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E326-35. doi: 10.1152/ajpendo.00153.2011. Epub 2011 May 3. Am J Physiol Endocrinol Metab. 2011. PMID: 21540448
-
Obesity, adipokines and cancer: an update.Clin Endocrinol (Oxf). 2015 Aug;83(2):147-56. doi: 10.1111/cen.12667. Epub 2014 Dec 29. Clin Endocrinol (Oxf). 2015. PMID: 25393563 Review.
-
Adiponectin in inflammatory and immune-mediated diseases.Cytokine. 2013 Oct;64(1):1-10. doi: 10.1016/j.cyto.2013.06.317. Epub 2013 Jul 11. Cytokine. 2013. PMID: 23850004 Free PMC article. Review.
Cited by
-
The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?Cancers (Basel). 2022 May 30;14(11):2709. doi: 10.3390/cancers14112709. Cancers (Basel). 2022. PMID: 35681689 Free PMC article. Review.
-
The Emerging Role of Adiponectin in Female Malignancies.Int J Mol Sci. 2019 Apr 30;20(9):2127. doi: 10.3390/ijms20092127. Int J Mol Sci. 2019. PMID: 31052147 Free PMC article. Review.
-
Serum levels of HMW adiponectin and its receptors are associated with cytokine levels and clinical characteristics in chronic obstructive pulmonary disease.Open Med (Wars). 2024 Feb 5;19(1):20240904. doi: 10.1515/med-2024-0904. eCollection 2024. Open Med (Wars). 2024. PMID: 38463522 Free PMC article.
-
The Role of Adipokines in Tumor Progression and Its Association with Obesity.Biomedicines. 2024 Jan 3;12(1):97. doi: 10.3390/biomedicines12010097. Biomedicines. 2024. PMID: 38255203 Free PMC article. Review.
-
Hyperinsulinemia and Hypoadiponectinemia are Associated with Increased Risk for Occurrence of Ovarian Cancer in Non-diabetic Women of North Indian Population.Indian J Clin Biochem. 2021 Apr;36(2):221-227. doi: 10.1007/s12291-020-00891-9. Epub 2020 May 13. Indian J Clin Biochem. 2021. PMID: 33867714 Free PMC article.
References
-
- Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., Mullany E.C., Biryukov S., Abbafati C., Abera S.F., et al. Global, regional and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–781. doi: 10.1016/S0140-6736(14)60460-8. - DOI - PMC - PubMed
-
- Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects) Lu Y., Hajifathalian K., Ezzati M., Woodward M., Rimm E.B., Danaei G. Metabolic mediators of the effects of body-mass index, overweight and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383:970–983. doi: 10.1016/S0140-6736(13)61836-X. - DOI - PMC - PubMed
-
- Global BMI Mortality Collaboration. Di Angelantonio E., Bhupathiraju S., Wormser D., Gao P., Kaptoge S., Berrington de Gonzalez A., Cairns B., Huxley R., Jackson C., et al. Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–786. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous